Sex
| Female | 11 (73) | 4 (57) | 3 (60) |
Male | 4 (27) | 3 (43) | 2 (40) |
Location
| Rural | 6 (40) | 6 (86) | 1 (20) |
Urban | 9 (60) | 1 (14) | 4 (80) |
Age, years
| 30–39 | 1 (7) | 1 (14) | 2 (40) |
40–49 | 1 (7) | 1 (14) | 1 (20) |
50–59 | 0 (0) | 0 (0) | 1 (20) |
60–69 | 8 (53) | 3 (43) | 1 (20) |
70–79 | 3 (20) | 1 (14) | 0 (0) |
80–89 | 2 (13) | 1 (14) | 0 (0) |
Years with hypothyroidism
| ≤5 | 2 (13) | 1 (14) | 3 (60) |
6–10 | 2 (13) | 4 (57) | 0 (0) |
11–20 | 5 (33) | 1 (14) | 2 (40) |
>20 | 6 (40) | 1 (14) | 0 (0) |
Other relevant health conditions
| Coeliac disease | 0 (0) | 0 (0) | 0 (0) |
Pernicious anaemia | 2 (13) | 0 (0) | 0 (0) |
Gastrointestinal (gallstones/diverticulitis/irritable bowel syndrome/twisted bowel/constipation) | 4 (27) | 2 (29) | 2 (40) |
Type 2 diabetes | 3 (20) | 0 (0) | 0 (0) |
Other relevant medications
| Calcium-containing drugs | 3 (20) | 0 (0) | 1 (20) |
Iron-containing drugs | 0 (0) | 1 (14) | 1 (20) |
Proton pump inhibitors | 3 (20) | 1 (14) | 1 (20) |
BMI
| <20 | 1 (7) | 0 | 0 |
20–25 | 5 (33) | 1 (14) | 2 (40) |
26–30 | 5 (33) | 5 (71) | 2 (40) |
31–35 | 3 (20) | 1 (14) | 1 (20) |
36–40 | 1 (7) | 0 | 0 |
Daily levothyroxine dose, µg
| 25 | 1 (7) | 0 | 0 |
50 | 1 (7) | 0 | 0 |
75 | 2 (13) | 0 | 0 |
100 | 3 (20) | 2 (29) | 2 (40) |
125 | 3 (20) | 2 (29) | 3 (60) |
150 | 2 (13) | 0 | 0 |
175 | 0 (0) | 0 | 0 |
200 | 0 (0) | 0 | 0 |
225 | 0 (0) | 1 (14) | 0 |
100/125 alternate day dosing | 1 (7) | 1 (14) | 0 |
100/75 alternate day dosing | 0 (0) | 1 (14) | 0 |
100 Monday–Friday, 75 Saturday–Sunday | 2 (13) | 0 | 0 |